glp 1 alternative otc GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More This product is not intended to diagnose Natural GLP-1 Support & Cravings

Presentation of Results The results are presented in a narrative report that summarizes the extracted data

GLG retrieved the main articles included in the review

Wharton S, Davies M, Dicker D, et al

AACE Clin Case Rep 5(3):e197e200

The results of SELECT, which examined the effect of subcutaneous semaglutide injection for the prevention of cardiovascular events in 17,604 patients with obesity (body mass index [BMI] 27 kg/m 2 ) and established cardiovascular disease but without diabetes, were presented in 2023 [25]

ESSENCE Phase 3 semaglutide in MASH data supported FDA approval in March 2024 , creating a premium pricing tier in a disease category with USD 17.4 billion addressable market and no prior approved pharmacotherapy